Skip to main content
SpringerLink
Log in

Deficit Schizophrenia

  • Chapter
  • First Online:
Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches

  • 1104 Accesses

Abstract

Schizophrenia patients show symptoms in the framework of negative, positive, affective, disorganized, and cognitive dimensions. In particular, a relationship between neurocognitive impairment, negative symptoms, and disorganization has been detected, featuring the so-called deficit schizophrenia. In this context, we here present a clinical case of severe schizophrenia characterized by neurocognitive dysfunction, altered functionality, negative symptoms, and imaging abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bleuler E. Die Prognose der Dementia Praecox (Schizophreniegruppe). Allg Zeitschrift für Psychiatr und Psych Medizin. 1908;31:436–80.

    Google Scholar 

  2. Braff DL, Ryan J, Rissling AJ, et al. Lack of use in the literature from the last 20 years supports dropping traditional schizophrenia subtypes from DSM-5 and ICD-11. Schizophr Bull. 2013;39(4):751–3.

    Article  Google Scholar 

  3. Griswold KS, Del Regno PA, Berger RC. Recognition and differential diagnosis of psychosis in primary care. Am Fam Physician. 2015;91(12):856–63.

    PubMed  Google Scholar 

  4. Salokangas RKR. Symptom dimensions and outcome in schizophrenia. World Psychiatry. 2003;2(3):172–8.

    PubMed  PubMed Central  Google Scholar 

  5. Altamura AC, Caletti E, Paoli RA, et al. Correlation between neuropsychological and social cognition measures and symptom dimensions in schizophrenic patients. Psychiatry Res. 2015;230(2):172–80.

    Article  Google Scholar 

  6. Cohen AS, Brown LA, Minor KS. The psychiatric symptomatology of deficit schizophrenia: a meta-analysis. Schizophr Res. 2010;118(1–3):122–7.

    Article  Google Scholar 

  7. Bozikas VP, Kosmidis MH, Kioperlidou K, et al. Relationship between psychopathology and cognitive functioning in schizophrenia. Compr Psychiatry. 2004;45(5):392–400.

    Article  Google Scholar 

  8. Carpenter WT, Heinrichs DW, Wagman AM. Deficit and non deficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145(5):578–83.

    Article  Google Scholar 

  9. Grover S, Kulhara P. Deficit schizophrenia: concept and validity. Indian J Psychiatry. 2008;50:61–6.

    Article  Google Scholar 

  10. Kirkpatrick B, Buchanan RW, Ross DE, et al. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry. 2001;58(2):165.

    Article  CAS  Google Scholar 

  11. Keefe RS, Frescka E, Apter SH, et al. Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings. Am J Psychiatry. 1996;153(6):806–11.

    Article  CAS  Google Scholar 

  12. Jablensky A. The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues Clin Neurosci. 2010;12(3):271–87.

    PubMed  PubMed Central  Google Scholar 

  13. Hovington CL, Lepage M. Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia. Expert Rev Neurother. 2012;12(1):53–69.

    Article  Google Scholar 

  14. Olabi B, Ellison-Wright I, AM MI, et al. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry. 2011;70(1):88–96.

    Article  Google Scholar 

  15. Ho B-C, Andreasen NC, Nopoulos P, et al. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry. 2003;60(6):585.

    Article  Google Scholar 

  16. Bora E, Binnur Akdede B, Alptekin K, et al. Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis. Psychol Med. 2017;47(14):2401–13.

    Article  CAS  Google Scholar 

  17. Fervaha G, Agid O, Foussias G, et al. Neurocognitive impairment in the deficit subtype of schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2016;266:397.

    Article  Google Scholar 

  18. Morrens M, Hulstijn W, Sabbe B. Psychomotor slowing in schizophrenia. Schizophr Bull. 2007;33(4):1038–53.

    Article  Google Scholar 

  19. Bervoets C, Docx L, Sabbe B, et al. The nature of the relationship of psychomotor slowing with negative symptomatology in schizophrenia. Cogn Neuropsychiatry. 2014;19:36–46.

    Article  Google Scholar 

  20. Cohen AS, Saperstein AM, Gold JM, et al. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr Bull. 2007;33(5):1201–12.

    Article  Google Scholar 

  21. Yu M, Tang X, Wang X, et al. Neurocognitive impairments in deficit and non-deficit schizophrenia and their relationships with symptom dimensions and other clinical variables. PLoS One. 2015;10(9):e0138357.

    Article  Google Scholar 

  22. APA. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association; 2013.

    Google Scholar 

  23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders—DSM-IV-TRH. 4th ed. Arlington: American Psychiatric Publishing; 2000.

    Google Scholar 

  24. Ventura J, Thames AD, Wood RC, et al. Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits. Schizophr Res. 2010;121(1):1–14.

    Article  Google Scholar 

  25. Sarfati Y, Hardy-Baylé M-C, Brunet E, et al. Investigating theory of mind in schizophrenia: influence of verbalization in disorganized and non-disorganized patients. Schizophr Res. 1999;37(2):183–90.

    Article  CAS  Google Scholar 

  26. Hardy-Baylé M-C, Sarfati Y, Passerieux C. The cognitive basis of disorganization symptomatology in schizophrenia and its clinical correlates: toward a pathogenetic approach to disorganization. Schizophr Bull. 2003;29(3):459–71.

    Article  Google Scholar 

  27. Uhlhaas PJ, Philips W, Mitchell G, et al. Perceptual grouping in disorganized schizophrenia. Psychiatry Res. 2006;145(2):105–11.

    Article  Google Scholar 

  28. Takahashi H, Iwase M, Nakahachi T, et al. Spatial working memory deficit correlates with disorganization symptoms and social functioning in schizophrenia. Psychiatry Clin Neurosci. 2005;59(4):453–60.

    Article  Google Scholar 

  29. Knight C, Alderman N, Burgess PW. Development of a simplified version of the multiple errands test for use in hospital settings. Neuropsychol Rehabil. 2002;12(3):231–55.

    Article  Google Scholar 

  30. Nestsiarovich A, Obyedkov V, Kandratsenka H, et al. Disorganization at the stage of schizophrenia clinical outcome: clinical–biological study. Eur Psychiatry. 2017;42:44–8.

    Article  CAS  Google Scholar 

  31. Toulopoulou T, Murray RM. Verbal memory deficit in patients with schizophrenia: an important future target for treatment. Expert Rev Neurother. 2004;4(1):43–52.

    Article  Google Scholar 

  32. Jablenski A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry. 2006;11:815–36.

    Article  Google Scholar 

  33. Goldberg TE, David A, Gold JM. Neurocognitive deficits in schizophrenia. In: Hirsch SR, Weinberger DR, editors. Schizophrenia. 2nd ed. Cambridge: Blackwell; 2003. p. 168–84.

    Chapter  Google Scholar 

  34. Brazo P, Marie RM, Halbecq BK, Segard L, Delamillieure P, et al. Cognitive patterns in subtypes of schizophrenia. Eur Psychiatry. 2002;17:155–62.

    Article  CAS  Google Scholar 

  35. Hill SK, Ragland JD, Gur RC, Gur RE. Neuropsychological differences among empirically derived clinical subtypes of schizophrenia. Neuropsychology. 2001;15:492–501.

    Article  CAS  Google Scholar 

  36. Ellison-Wright I, Glahn DC, Laird AR, et al. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry. 2008;165(8):1015–23.

    Article  Google Scholar 

  37. Voineskos AN, Foussias G, Lerch J, et al. Neuroimaging evidence for the deficit subtype of schizophrenia. JAMA Psychiat. 2013;70(5):472–80.

    Article  Google Scholar 

  38. Wolkin A, Sanfilipo M, Wolf AP, et al. Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry. 1992;49(12):959–65.

    Article  CAS  Google Scholar 

  39. Potkin SG, Alva G, Fleming K, et al. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am J Psychiatry. 2002;159(2):227–37.

    Article  Google Scholar 

  40. Kaplan RD, Szechtman H, Franco S, et al. Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET). Schizophr Res. 1993;11(1):47–54.

    Article  CAS  Google Scholar 

  41. Horga G, Parellada E, Lomeña F, et al. Differential brain glucose metabolic patterns in antipsychotic-naïve first-episode schizophrenia with and without auditory verbal hallucinations. J Psychiatry Neurosci. 2011;36(5):312–21.

    Article  Google Scholar 

  42. Sham PC, Castle DJ, Wessely S, et al. Further exploration of a latent class typology of schizophrenia. Schizophr Res. 1996;20(1–2):105–15.

    Article  CAS  Google Scholar 

  43. Janicak PG, Glick ID, Marder SR, et al. The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies. J Clin Psychiatry. 2009;70:25–35.

    Article  CAS  Google Scholar 

  44. Robinson DG, Gallego JA, John M, et al. A randomized comparison of Aripiprazole and Risperidone for the acute treatment of first-episode schizophrenia and related disorders: 3-month outcomes. Schizophr Bull. 2015;41(6):1227–36.

    Article  Google Scholar 

  45. Yeh C-B, Huang Y-S, Tang C-S, et al. Neurocognitive effects of aripiprazole in adolescents and young adults with schizophrenia. Nord J Psychiatry. 2014;68(3):219–24.

    Article  Google Scholar 

  46. Wykes T, Huddy V, Cellard C, et al. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011;168(5):472–85.

    Article  Google Scholar 

  47. Cella M, Preti A, Edwards C, et al. Cognitive remediation for negative symptoms of schizophrenia: a network meta-analysis. Clin Psychol Rev. 2017;52:43–51.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Department of Neurosciences and Mental Health, University of Milan, Milan, Italy

    R. A. Paoli & M. Grottaroli

Authors
  1. R. A. Paoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Grottaroli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. A. Paoli .

Editor information

Editors and Affiliations

  1. Department of Neuroscience and Mental Health, IRCCS Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

    Alfredo Carlo Altamura

  2. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy, IRCCS “E. Medea” Scientific Institute, Bosisio Parini (Lc), Italy

    Paolo Brambilla

Self-Assessment Questionnaire

Self-Assessment Questionnaire

  1. 1.

    Which is the most important clinical aspect to evaluate in follow-up of the patient after clinical stabilization?

    • (A) Neurocognition

    • (B) Socioeconomic status

    • (C) Interpersonal relationships

    • (D) Subjective well-being

  2. 2.

    Which is the best rehabilitative option for deficit schizophrenia?

    • (A) CBT

    • (B) CRT

    • (C) Family therapy

    • (D) A, B, C

  3. 3.

    What supposed dimension of schizophrenia has been found linked to severe neurocognitive alterations?

    • (A) Paranoid

    • (B) Aggressive and hostility

    • (C) Negative and disorganization

    • (D) Affective

  4. 4.

    Which factors have a significant role in administering long-acting therapy?

    • (A) Patient prefers not to take pills

    • (B) Non-compliance with pharmacological treatment

    • (C) Stabilization of plasma levels

    • (D) A + B + C

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Paoli, R.A., Grottaroli, M. (2019). Deficit Schizophrenia. In: Altamura, A., Brambilla, P. (eds) Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches. Springer, Cham. https://doi.org/10.1007/978-3-319-91557-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91557-9_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-91556-2

  • Online ISBN: 978-3-319-91557-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation